| 查看: 341 | 回复: 8 | |||
| 当前主题已经存档。 | |||
| 当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖 | |||
lw1966hhh铁杆木虫 (著名写手)
|
[交流]
《Insights The Cancer Market Outlook to 2009》
|
||
|
This report quantifies the patient potential in different cancer sub-markets and provides benchmarks for new cancer drug development and marketing strategies; identifying key areas of unmet need and profiling the market leading products of the future. The global cancer market is characterized by a mix of established gold standard therapies and new innovative products rapidly capturing market share. While a number of blockbuster therapies lose patent protection, heavy R&D investment has resulted in 400 potential new drugs currently progressing through clinical trials. Significant unmet needs and high incidence of disease continue to drive market growth, leaving a number of companies competing to improve treatment efficacy and drive market share. Use this report to quantify patient potential in cancer sub-markets, benchmark your portfolio against the eight leading companies in the sector and devise strategies to counter threats to your market position in the next five years. http://rapidshare.de/files/28238 ... Outlook_to_2009.pdf |
» 猜你喜欢
合成
已经有0人回复
氨基酸的酰化反应,求大佬解答
已经有0人回复
药理学论文润色/翻译怎么收费?
已经有164人回复
26年申博——已发SCI6篇
已经有13人回复
碱缸的配制
已经有5人回复
新!澳门科技大学诚招2026年秋季药剂学/生物材料方向博士研究生(申请-考核制)
已经有18人回复
澳科大药学院诚招2026年秋季纳米医学/生物材料博士研究生
已经有16人回复
医药口服制剂辅料应用
已经有0人回复
全新推出Tguide®靶向递送方案,突破99% T细胞转染效率
已经有1人回复
Mal-LN29-LNP-mRNA 试剂盒:自带Mal基团,一盒实现抗体筛选与体内靶向验证
已经有0人回复

yangdongyu
银虫 (小有名气)
- 应助: 0 (幼儿园)
- 贵宾: 0.138
- 金币: 475.5
- 帖子: 205
- 在线: 5.5小时
- 虫号: 7828
- 注册: 2003-04-22
- 性别: GG
- 专业: 抗肿瘤药物药理
7楼2007-03-08 21:54:05












回复此楼